Cuprizone-induced demyelination in CNP::GFP transgenic mice

Area of Science:

• Neuroscience
• Cell Biology
• Demyelination Models

Background:

• Cuprizone (bis-cyclohexanone oxaldihydrazone) is a known inducer of demyelination in the central nervous system.
• Oligodendroglial (OLG) lineage cells are responsible for myelin production and maintenance.
• Understanding OLG response to demyelination is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the extent of oligodendroglial cell damage and recovery in the cuprizone demyelination model.
• To utilize transgenic mice expressing enhanced green fluorescent protein (GFP) under the 2'-3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) promoter for OLG lineage tracking.
• To assess the impact of cuprizone on various brain structures and identify affected cell populations.

Main Methods:

• Induction of demyelination using cuprizone in CNPase-GFP transgenic mice.
• Monitoring of GFP+ cells to track oligodendroglial lineage cells (OLG precursors to mature OLGs).
• Assessment of myelin basic protein (MBP) expression, astrogliosis (GFAP expression), and microglial activation.

Main Results:

• Cuprizone exposure led to a generalized loss of GFP+ oligodendroglial cells across numerous brain structures, including the corpus callosum, caudatus putamen, cortex, and hippocampus.
• Oligodendroglial cell depletion correlated with reduced myelin basic protein expression.
• Extensive astrogliosis and microglial activation were observed, while neurons remained unaffected.
• Subventricular zone cells showed increased proliferation.
• Following cuprizone withdrawal, GFP+ oligodendroglial cells repopulated damaged areas, with GFP expression preceding myelin basic protein restoration.

Conclusions:

• The cuprizone model affects oligodendroglial cells more broadly than previously recognized.
• GFP expression serves as an early indicator of oligodendroglial cell presence before myelin repair.
• The study highlights the dynamic nature of oligodendroglial cell damage and recovery in the central nervous system.